Myelopathies in patients with cancer

Jerome J. Graber, Craig P. Nolan

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Myelopathy is a devastating neurologic complication of cancer. The resulting pain, paralysis, and incontinence can turn a patient with cancer from a functioning individual to one who is confined to a chair or bed. Early diagnosis and appropriate therapy can prevent or ameliorate these symptoms and improve both duration of survival and quality of life. Accurate neurologic assessment of patients is crucial for early diagnosis and correct therapy. Myelopathy in patients with cancer is not rare. Epidural spinal cord compression (SCC) affects an estimated 5% of patients with cancer; other disorders such as intramedullary spinal cord metastases, adverse effects of therapy, and paraneoplastic spinal cord syndromes, although less common, are equally devastating. Because of space limitations, this review addresses the pathophysiology, clinical findings, diagnosis, and treatment of only some of the myelopathies that affect patients with cancer (Table 1). Because of new data, epidural SCC and paraneoplastic syndromes are emphasized.

Original languageEnglish (US)
Pages (from-to)298-304
Number of pages7
JournalArchives of Neurology
Volume67
Issue number3
DOIs
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Spinal Cord Diseases
Spinal Cord Compression
Neoplasms
Nervous System
Early Diagnosis
Spinal Cord
Paraneoplastic Syndromes
Therapeutics
Paralysis
Quality of Life
Cancer
Neoplasm Metastasis
Pain
Survival
Cord
Therapy
Compression
Syndrome

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Myelopathies in patients with cancer. / Graber, Jerome J.; Nolan, Craig P.

In: Archives of Neurology, Vol. 67, No. 3, 03.2010, p. 298-304.

Research output: Contribution to journalArticle

Graber, Jerome J. ; Nolan, Craig P. / Myelopathies in patients with cancer. In: Archives of Neurology. 2010 ; Vol. 67, No. 3. pp. 298-304.
@article{4632cff1dc5847f1b30d2d1dada9dcf6,
title = "Myelopathies in patients with cancer",
abstract = "Myelopathy is a devastating neurologic complication of cancer. The resulting pain, paralysis, and incontinence can turn a patient with cancer from a functioning individual to one who is confined to a chair or bed. Early diagnosis and appropriate therapy can prevent or ameliorate these symptoms and improve both duration of survival and quality of life. Accurate neurologic assessment of patients is crucial for early diagnosis and correct therapy. Myelopathy in patients with cancer is not rare. Epidural spinal cord compression (SCC) affects an estimated 5{\%} of patients with cancer; other disorders such as intramedullary spinal cord metastases, adverse effects of therapy, and paraneoplastic spinal cord syndromes, although less common, are equally devastating. Because of space limitations, this review addresses the pathophysiology, clinical findings, diagnosis, and treatment of only some of the myelopathies that affect patients with cancer (Table 1). Because of new data, epidural SCC and paraneoplastic syndromes are emphasized.",
author = "Graber, {Jerome J.} and Nolan, {Craig P.}",
year = "2010",
month = "3",
doi = "10.1001/archneurol.2010.20",
language = "English (US)",
volume = "67",
pages = "298--304",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Myelopathies in patients with cancer

AU - Graber, Jerome J.

AU - Nolan, Craig P.

PY - 2010/3

Y1 - 2010/3

N2 - Myelopathy is a devastating neurologic complication of cancer. The resulting pain, paralysis, and incontinence can turn a patient with cancer from a functioning individual to one who is confined to a chair or bed. Early diagnosis and appropriate therapy can prevent or ameliorate these symptoms and improve both duration of survival and quality of life. Accurate neurologic assessment of patients is crucial for early diagnosis and correct therapy. Myelopathy in patients with cancer is not rare. Epidural spinal cord compression (SCC) affects an estimated 5% of patients with cancer; other disorders such as intramedullary spinal cord metastases, adverse effects of therapy, and paraneoplastic spinal cord syndromes, although less common, are equally devastating. Because of space limitations, this review addresses the pathophysiology, clinical findings, diagnosis, and treatment of only some of the myelopathies that affect patients with cancer (Table 1). Because of new data, epidural SCC and paraneoplastic syndromes are emphasized.

AB - Myelopathy is a devastating neurologic complication of cancer. The resulting pain, paralysis, and incontinence can turn a patient with cancer from a functioning individual to one who is confined to a chair or bed. Early diagnosis and appropriate therapy can prevent or ameliorate these symptoms and improve both duration of survival and quality of life. Accurate neurologic assessment of patients is crucial for early diagnosis and correct therapy. Myelopathy in patients with cancer is not rare. Epidural spinal cord compression (SCC) affects an estimated 5% of patients with cancer; other disorders such as intramedullary spinal cord metastases, adverse effects of therapy, and paraneoplastic spinal cord syndromes, although less common, are equally devastating. Because of space limitations, this review addresses the pathophysiology, clinical findings, diagnosis, and treatment of only some of the myelopathies that affect patients with cancer (Table 1). Because of new data, epidural SCC and paraneoplastic syndromes are emphasized.

UR - http://www.scopus.com/inward/record.url?scp=77749310139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749310139&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2010.20

DO - 10.1001/archneurol.2010.20

M3 - Article

VL - 67

SP - 298

EP - 304

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 3

ER -